Business Description
Statera BioPharma Inc
NAICS : 325412
SIC : 2834
ISIN : US8575611046
Share Class Description:
STAB: Ordinary SharesCompare
Compare
Traded in other countries / regions
STAB.USA7CB.Germany IPO Date
2021-07-28Description
Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction. Its proprietary platform of Toll-like receptor drug candidates has applications in mitigation of radiation injury, mitigation of T-cell exhaustion, inflammation, T-cell exhaustion, immune system dysfunction, oncology, infection and neutropenia.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 99.97 | |||||
9-Day RSI | 85.22 | |||||
14-Day RSI | 55.82 | |||||
6-1 Month Momentum % | -50 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History |
|---|
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Yield % | -87107.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:STAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Statera BioPharma Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.517 | ||
| Beta | 466.9129 | ||
| 3-Year Sharpe Ratio | 0.03 | ||
| 3-Year Sortino Ratio | 0.05 | ||
| Volatility % | 243.03 | ||
| 14-Day RSI | 55.82 | ||
| 14-Day ATR ($) | 0.000054 | ||
| 20-Day SMA ($) | 0.00011 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 0.0001 - 0.0266 | ||
| Shares Outstanding (Mil) | 71.42 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Statera BioPharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Statera BioPharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-09 | In 103 days | ||
| Second quarter earnings results for 2026 | 2026-08-24 | In 26 days | ||
| First quarter earnings results for 2026 | 2026-08-03 | In 5 days |
Show
Entries
Statera BioPharma Inc Frequently Asked Questions
What is Statera BioPharma Inc(STAB)'s stock price today?
The current price of STAB is $0.00. The 52 week high of STAB is $0.03 and 52 week low is $0.00.
When is next earnings date of Statera BioPharma Inc(STAB)?
The next earnings date of Statera BioPharma Inc(STAB) is 2026-08-03 Est..
Does Statera BioPharma Inc(STAB) pay dividends? If so, how much?
Statera BioPharma Inc(STAB) does not pay dividend.
Guru Commentaries on OTCPK:STAB
No articles.
Press Release
Articles on Statera BioPharma Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers